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Abstract  sandhoff disease is a rare and severe lysosomal 
storage  disorder  representing  7% of GM2 gangliosidoses. 
Bilateral  thalamic  involvement  has  been  suggested  as 
a  diagnostic  marker  of  sandhoff  disease.  A  case  of  an 
18-month-old  infant  admitted  for  psychomotor  regres-
sion  and  drug  resistant  myoclonic  epilepsy  is  presented. 
Cerebral  CT  scan  showed  bilateral  and  symmetrical  tha-
lamic  hyperdensity.  MrI  revealed  that  the  thalamus  was 
hyperintense  on  T1-weighted  images  and  hypointense  on 
T2-weighted  images  with  a  hypersignal  T2  of  the  white 
matter. Enzymatic assays objectified a deficiency of both 






order caused by a deficiency of both hexosaminidases A 
and B resulting in accumulation of glycosphingolipids and 
oligosaccharides in  the brain. It  represents 7% of cases of 









inity of the first degree of the parents and the death of a 
brother at the age of 16 months under unspecified circums-
tances. The other brother and sister were unaffected.
The  onset  of  clinical  symptoms  began  at  the  age  of 






problems or  responsiveness  to  light. ophthalmologic exa-
mination showed a cherry-red spot without optic atrophy.






























sandhoff  diseases)  or  GM1  gangliosidosis  (e.g.  Landing 
disease), Canavan disease or Alexander disease.
Chromatography of amino acids in the blood, urine and 
cerebrospinal fluid (CSF) was normal and chromatography 
of organic  acids  in  the urine was  also normal. enzymatic 
assays were performed in France and revealed a deficiency 
of both hexosaminidases A and B confirming the diagnosis 
of sandhoff disease.
Discussion
sandhoff  disease  is  a  rare  autosomal  recessive  inherited 
metabolic disorder caused by mutations in the HEXB gene 




form  is  the most  common and  severe  form, clinical onset 
is generally between 3 and 9 months of age after a normal 
development  and  is  characterized  by  muscular  hypotonia 
and  tonico-clonic  or  myoclonic  seizures,  blindness,  psy-
chomotor  retardation  and  paralysis  [1]. A  cherry-red  spot 
in macular areas is characteristic but not specific. Juvenile 
and  adult  onset  forms  of  sandhoff  disease  are  very  rare. 















Cerebral  images  of  GM2  gangliosidosis  have  been 
published in a few reports and bilateral homogeneous thala-
mic hyperdensity on CT was reported to be an early sign [3]. 
Loss  of  axons  and myelin  in  the  central  cortical  neurons, 
gliosis  and  intralysosomal  storage  in  addition  to  calcium 
accumulation might be responsible for this appearance [4].
Magnetic  resonance  imaging  (MrI)  typically  reveals 
hypo-intensity  in T2-weighted  images of  the  thalamus  [5] 
and  high  signal  abnormalities  have  been  reported  in  T2-








nal  capsule  involvement  and  descended  downward  along 
the long fiber tracts of the pons through the crus cerebri.
recently, Lowe et al. found an additional 2.07 ppm reso-
nance in proton MrI spectra of the brain of sandhoff mice 
which could be identified as originating from N-acetylhe-
xosamine  [8]. Wilken  et  al.  reported  similar  proton Mrs 
findings in a child with enzymatically proven Sandhoff 






tified in Tay-Sachs disease GM1 gangliosidoses and in late 
stages of Canavan disease or Krabbe’s disease. Patients with 
late stage Canavan disease may have dense thalami on T1-
weighted  images,  as well  as white matter  necrosis,  resul-
ting  in  cavitation  and  brain  stem  and  cerebellar  atrophy, 
which are not observed in GM1 gangliosidoses. In Krab-




Diagnosis is confirmed by enzymatic assays revealing a 







her disease-specific MRS pattern of the brain.
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